Events
Conferences, congresses and webinars where Philogen presents its science.
Philogen is pleased to invite you to an upcoming webinar on September 25, 2026, at 14:00 GMT | 15:00 CET.
During the session, our management team will provide an update on the latest scientific and financial results. To register, please click on the link or contact…
Philogen to attend the Society of Nuclear Medicine and Molecular Imaging (SNMM) annual meeting on May 30 – June 2, 2026
Prof. Philipp Backhaus will give a presentation on “Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET and first experience…
Philogen to attend the Festival of Biologics, 13-15 October 2026
Dr. Ettore Gilardoni will give an oral presentation entitled “Charge Variants characterization of a noncovalent dimeric fusion protein”. Follow the link for…
Philogen to attend the Summer School in Pharmaceutical Analysis, 21-23 September 2026
Dr. Ettore Gilardoni is giving a lecture entitled “Mass Spectrometry Applications For Targets And Hit Compounds Identification”. Follow the link for more…
Philogen to attend the 74th American Society Mass Spectrometry annual conference in San Diego, May 31 – June 4 2026
Dr. Ettore Gilardoni will present a poster entitled “Mass Spectrometry–Based Atlas of the Blood-Accessible Surface Proteome in Syngeneic Brain Tumor Models”…
Philogen to attend EADO 2026, 23-25 April 2026
Prof. Thomas Eigentler will give a talk entitled “Intralesional L19IL2/L19TNF in high-risk lacSCC patients: results from the Phase II DUNCAN Trial Exploratory…
Philogen to attend AACR 2026 in San Diego, 17-22 April 2026
Dr. Matilde Bocci is presenting a poster entitled “FAP-targeting Small molecule-immunostimulator conjugate bearing a novel TLR7 agonist payload induces tumor…
Philogen is pleased to invite you to an upcoming webinar on March 30, 2026, at 15:00 GMT | 16:00 CET
During the session, our management team will provide an update on the latest scientific and financial results. To register, please click on the link or contact…
Philogen is pleased to invite you to an upcoming webinar on November 20, 2025, at 15:00 GMT | 16:00 CET.
During the session, our management team will provide an update on the latest scientific and financial results. To register, please click on the link in the…
Philochem to attend the Festival of Biologics 2025 in Basel on September 30-October 2, 2025
Dr. Emanuele Puca will give an oral presentation entitled: “Antibody-cytokine Fusions for Cancer Therapy: Late-Stage Clinical Results” Dr. Roberto de Luca will…
Philogen is pleased to invite you to an upcoming webinar on September 26, 2025, at 14:00 GMT | 15:00 CET.
During the session, our management team will provide an update on the latest scientific and financial results. To register, please click on the link or contact…
Philogen to attend the European Society of Nuclear Medicine (EANM) annual meeting on October 4 – 8, 2025
Dr. Samuele Cazzamalli is presenting “From DNA-encoded chemistry to ACP3-targeted radioligand therapeutics against prostate cancer”. In addition, Dr. Cristiano…
Philogen to attend the Biopharma and Life Sciences Private Event in London (UK) on November 18, 2025
Prof. Dario Neri will participate to the event, which will convene a distinguished community of executives, investors and thought leaders in BioPharma and Life…
Philogen Management to hold a Webinar to provide an update on Nidlegy™ Marketing Authorization Application in Melanoma.
The Webinar will take place on June 25 at 10:00 ET | 15:00 GMT | 16:00 CET. Please use this link to register to the event or contact us at ir@philogen.com
Philogen is pleased to invite you to a webinar with Prof. Dario Neri, taking place today, June 11, at 11:00 ET | 17:00 CET.
Following last night’s announcement regarding OncoACP3, we are pleased to invite you to a webinar with Prof. Dario Neri, taking place today, June 11, at 11:00…
Philogen to attend the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting on June 21-24, 2025
Dr. Philipp Backhaus is giving a presentation entitled “A new theranostic target in prostate cancer: First results from prostatic acid phosphatase (ACP3)…
Philogen to attend AACR 2025 on April 25-30, 2025
Claudia Comacchio is presenting a poster about Philochem’s ACP3 antibody therapeutics on April 29, entitled “Generation and in vivo characterization of a novel…
Philogen to attend the PEGS Boston 2025 on May 13-16, 2025
Dr. Sebastian Oehler will present Philochem’s recent discovery in the field of prostate cancer under the title “From DNA-Encoded Chemistry to ACP3-Targeted…
Philogen FY 2024 report on April 2, 2025
Philogen is pleased to invite you to an upcoming webinar on April 2, 2025, at 15:00 GMT | 16:00 CET. Click on the link to register or contact us at…
Philogen to attend a lecture at the Department of Dermatology, University of Tübingen in Tübingen (Germany) on November 6, 2024
Prof. Dario Neri gave a presentation on “Tumor targeting”
Philogen to attend the Congress of the Danish Society of Medicinal Chemistry and Chemical Biology (DSMKB) in Copenhagen (Denmark) on January 24, 2025
Prof. Dario Neri gave a presentation entitled: “From encoded chemical libraries to targeted anti-cancer therapeutics”
Philogen to attend the Group Retreat of the group of Prof. Dr. Markus Manz in Bergün (Switzerland) on September 9, 2024
Prof. Dario Neri gave a presentation on “Tumor targeting”
Philogen to attend a lecture at the Laboratory of Molecular Biology, Medical Research Council Centre in Cambridge (UK) on March 31, 2025
Prof. Dario Neri will give a presentation entitled: “From encoded combinatorial libraries to clinical-stage targeted therapeutics”
Philogen to attend PEGS Europe in Barcelona (Spain) on November 7, 2024
Prof. Dario Neri gave a presentation entitled: “Antibody-cytokine fusions for cancer therapy: late-stage clinical results”
Philogen to attend a lecture at AstraZeneca in Göteborg (Sweden) on May 29, 2024
Prof. Dario Neri gave a presentation entitled: “Tumor targeting: from encoded libraries to clinical-stage targeted therapeutics”
Philogen to attend the ZKB Investors Event in Zurich (Switzerland) on December 4, 2024
Prof. Dario Neri gave a presentation entitled: “Radiopharmaceuticals: an emerging class of anticancer drugs”
Prof. Dario Neri to give a lecture at the University of Siena (Italy) on March 22, 2024
The lecture is entitled: “Encoded combinatorial libraries: from ligand discovery to targeted therapeutics”
Philogen to attend the Institute for Chemical Immunology Conference 2024 in Leiden (The Netherlands) on June 28, 2024
Prof. Dario Neri gave a presentation entitled: “From encoded combinatorial libraries to clinical-stage targeted therapeutics”
Philogen to attend a lecture at the University of Catania in Catania (Italy) on January 16, 2025
Prof. Dario Neri gave a presentation entitled: “From encoded chemical libraries to clinical-stage targeted therapeutics”
Philogen to attend the European Association of Dermato-Oncology (EADO) Congress in Paris (France) on April 5, 2024
Prof. Dario Neri gave a presentation entitled: “Principles of ADC and bispecific antibodies”